Keyword results: Microsaic Systems

Microsaic Systems – “pleased to announce” trading update. Er, what about ‘profit’ & cash?

Microsaic Systems (MSYS) has issued a “pleased to announce” trading update, emphasising that “the launch of the Microsaic Services Division, earlier this year, has resulted in an uplift of 40% in revenues” and “a healthy order book for H2 2022 which is the strongest ever going in to the second half”. So what of a current little changed 0.08p share price, circa £5 million market capitalisation?...

Microsaic Systems – argues new agreement illustrates diversified potential. How significantly so?...

Microsaic Systems (MSYS) has announced a “Manufacturing Services Framework Agreement” which Acting Executive Chairman Gerard Brandon emphasises “diversifies the company's revenues beyond equipment sales of Mass Spectrometers… This new agreement illustrates how Microsaic is able to access additional revenues from other innovative companies seeking a high quality product design, development and manufacturing service”. What then of a current share price response more than 7% lower to 0.10p?...

Microsaic Systems – “trading update”. Forgot the loss and cash burn?

A trading update from mass spectrometry equipment company Microsaic Systems (MSYS) commences that “revenues for FY21 have significantly exceeded those of FY20, recovering to a level slightly ahead of that in FY19, a pre-pandemic benchmark” and includes CEO Glenn Tracey “absolutely delighted”. So what of a current share price response down to around 0.19p?…

Microsaic Systems – reckons “thrilled to report… transformational performance”, so why further share price decline?...

The CEO of Microsaic Systems (MSYS) Glenn Tracey is “thrilled to report this transformational performance for the first half of 2021”. The shares have responded to the half-year results announcement to currently 0.22p, more than 12% lower! So what’s going on?…

Deepverge – argues move to ‘open up additional opportunities’… so why a further share price fall?

Previously writing on Deepverge (DVRG), last month I warned as the shares moved ahead to 36p. Today the company makes an announcement CEO Gerard Brandon emphasises “opens up additional opportunities to jointly development new products and services by working with… experts adding smart AI cloud-based data analytic technologies and best-in-class engineering”. What’s the detail?…

Microsaic Systems – statement following recent share price increase. Any sale progress?, Er...

On 22nd December Microsaic Systems (MSYS) announced that it had appointed KRE Corporate Recovery “to explore other remaining options to maximise value for creditors and potentially other stakeholders”. It was “other remaining options” as a formal sale process had failed – and the shares fell back. However, they have recently significantly recovered and now a further statement from the company has been required…

PREMIUM CONTENT

Microsaic Systems – after formal sale process failure… it is very possibly toast

Shares in Microsaic Systems (MSYS) are down by 60% today. Mr Market is showing Christmas generosity, this stock is still anywhere between 60% and 100% too high…

Subscribe to ShareProphets to access Premium Content

Microsaic Systems – “pleased to announce” results & update on trading. Er!...

“Microsaic Systems plc (MSYS), the developer of point of need mass spectrometry instruments, is pleased to announce its unaudited interim results for the six months ended 30 June 2020 and an update on trading since the period end”. Encouraging then?…

Microsaic Systems – 2019 results & prospective fundraise “in light of… progress to date, and the planned expansion of the product portfolio”. Really?!...

“Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry instruments, is pleased to announce its audited financial results for the year ended 31 December 2019”. The shares have currently responded to 0.80p – 20% lower!…

Microsaic Systems – I wonder why it’s “pleased to announce” a new broker appointment “with immediate effect”...

Microsaic Systems (MSYS) “is pleased to announce the appointment of WH Ireland Limited as Joint Broker with immediate effect, alongside N+1Singer as Nominated Adviser and Joint Broker”. Hmmm – I wonder why?...

Microsaic Systems – “Global collaboration agreement” ramptastic, cash burn concerns?

Previously writing on developer of mass spectrometry instruments Microsaic Systems (MSYS) it was with the company arguing “encouraged with the progress made in the first half” but the shares down to 1.15p. They have since fallen further and today a “Global collaboration agreement with Axcend Corp”

Microsaic Systems – argues “encouraged with the progress made in the first half”… so why are the shares slumping?

“Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry instruments, is pleased to announce its unaudited interim results for the six months ended 30 June 2019”. The shares have currently responded to 1.15p – er, more than 25% lower!...

Microsaic Systems – trading “remains in line” & partnership phase 2 “completed successfully”, so why the share price fall?

An intra-day (11:20am) “Bioprocessing partnership update & trading update” from mass spectrometry instruments developer Microsaic Systems (MSYS). This firstly “confirms that trading in 2018 remains in line with the board's expectations” and then that phase two of the partnership “with a global partner in bioprocessing… has now been completed successfully, with a clear addressable market identified and positive feedback received from potential customers”. So why a 25% share price fall, towards 1p?...

Microsaic Systems – from in December sales to be “substantially ahead” of 2016’s, to now “significantly lower than for 2016”

“Trading Statement” announcement from Microsaic Systems (MSYS) includes Chairman Eric Yeatman commenting “we are very encouraged with the progress since our 21 March 2017 update, when we introduced our biopharma strategy, specifically around bioprocessing. We are engaging with several of the leading players in the global market for bioprocessing equipment”. However, the statement also includes that “the company now expects its H1 and full year 2017 revenue to be significantly lower than for 2016”. Hmmm…

Microsaic Systems – reckons “clear opportunities exist”, but it's a profit warning…

“Trading Statement” announcement from Microsaic Systems (MSYS) starts with that “it is expected that EBITDA and pre-tax profit for 2016 will be broadly in line with market expectations… The company has reshaped its business strategy to focus on the Pharma market where clear opportunities exist for the company's products”. Hmmm, “broadly in line” is of course ‘slightly behind’, though at least there’s “clear opportunities” ahead. Though, wait. What’s that? The shares currently down approaching 20%, towards 3p?!? …

Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments

|